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On the evolution of Avian infectious bronchitis virus in 
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Abstract
Avian infectious bronchitis virus (IBV) (Nidovirales: Coronaviridae) is a chicken Gammacoronavirus with the highest 
evolution rate in the genus and, despite the recently reported proofreading activity of its polymerase, intra and inter-
host diversity is a well documented phenomenon. This study aimed to assess the genetic variation of serial passages of 
a variant genotype IBV strain in vitro. Strain CRG-BETA, propagated in chicken embryos, was inoculated in VERO 
cells monolayers up to the 4th passage and each passage was monitored with an RT-PCR targeted to the S1 gene (nt 705 
to 1094) and an RT-PCR to the protein 5a mRNA. All passages were positive to RT-PCRs to S1 and passages 1 to 3 to 
5a mRNA; S1 sequences showed no polymorphism. The finding of IBV mRNA in the cell cultures demonstrates that 
the CRG-BETA IBV strain is replicating in the VERO cells and regarding S1 sequence analysis, the lack of nucleotide 
mutations shows that CRG-BETA might have reached a fixed status. As a conclusion, different genotypes of IBV present 
different evolutionary patterns not only in vivo as previously known, but also in vitro, as described herein. 
Keywords: IBV. Spike. Evolution. In vitro.
Resumo
O virus da bronquite infecciosa das galinhas (IBV) (Nidovirales: Coronaviridae) é um Gammacoronavirus com a maior 
taxa evolutiva no gênero e, apesar de uma recentemente relatada atividade corretiva de sua polimerase, a diversidade 
intra e inter-hospedeiros é um fenômeno bem documentado. Este estudo objetivou avaliar a variação genética após 
passagens seriais de uma amostra de IBV variante. A amostra CRG-BETA, propagada em embriões de galinhas, foi 
inoculada em monocamadas de células VERO até a quarta passagem e cada passagem foi monitorada com uma RT-
PCR para a região S1 do gene S (nt 705 a 1094) e uma RT-PCR para o mRNA da proteína 5a do vírus. Todas as passagens 
foram positivas para S1 e as passagens 1 a 3 para mRNA 5a; sequências de S1 não apresentaram polimorfismos. O 
encontro de mRNA de IBV nos cultivos celulares demonstra que a amostra CRG-BETA está replicando nas células 
VERO e, em relação à análise de S1, a ausência de mutações de nucleotídeos demonstra que a amostra CRG-BETA pode 
ter atingido um estado fixo. Como conclusão, diferentes genótipos de IBV apresentam diferentes padrões evolutivos não 
apenas in vivo, como previamente conhecido, mas também in vitro, como aqui relatado. 
Palavras-chave: IBV. Espícula. Evolução. In vitro.
Introduction
Avian infectious bronchitis virus (IBV), currently 
named as Avian coronavirus (Nidovirales: Coronaviri-
dae: Coronavirinae: Gammacoronavirus) is a world-
wide distributed major pathogen of breeders, broilers 
and layers, causing disease of the reproductive, respi-
ratory, urinary and enteric systems of the birds, with 
a high attack rate and a major economic impact to the 
poultry industry1.
IBV occurs as a wide range of genotypes and se-
rotypes due to the high prevalence of infection and 
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the high mutation rate, while the heterotypic protec-
tion amongst different serotypes distantly related is 
low2. This high evolutionary rate leads thus to a con-
tinued emergence of nucleotide and amino acids mu-
tations and eventually to the emergence of novel types 
of the virus3.
It’s known that a same initial population of IBV, i.e., 
a same quasispecies under a neutral network con-
straint, might go different evolutionary ways depend-
ing on the type of cell it infects in vivo4 and that even 
a low number of in vitro passages might result in lin-
eages divergent form the initial one5.
A typical Brazilian IBV lineage has been described6,7 
with at least three sub lineages3 consistently diver-
gent from the archetypical strains already described. 
Nonetheless, there’s no data on the effect of serial pas-
sages of these viruses neither in vivo nor in vitro.
As the knowledge on the molecular behavior of IBV 
is paramount for the knowledge on vaccine strain sta-
bility, the aim of this investigation was to assess the 
divergence of a Brazilian strain of IBV in cell culture 
based on a sequence of the spike envelope glycopro-
tein (S) gene, a major marker for diversity in this virus 
species.
Material and Method
Virus strains
The strain CRG-BETA isolated in chicken embryos 
(4th passage) and typed as Brazilian genotype was used 
for the in vitro inoculations. The H120 vaccine strain 
(Massachusetts serotype) was used as a positive con-
trol in the RT-PCRs (DEPC-treated water was used as 
the negative control).
Passages in VERO cells
Forty-eight hour-old confluent VERO cells grown 
in 25cm2 flasks with MEM (minimal essential medi-
um) with 10% phoetal bovine serum (PBS) were used 
for all inoculations. The growth medium was discard-
ed and 1mL of CRG-BETA (4th passage in embryos) 
was inoculated in the monolayers; 1mL of PBS-free 
MEM was inoculated in another flask of cells (mock-
infected).
After an one-hour adsorption at 37ºC, the inocula 
were not discarded and 6mL of MEM plus 2.5% PBS 
were added and the monolayers were kept at 37ºC for 
4 days. After this period, cells were frozen and thaw 
and 1 mL of each previous passage of CRG-BETA or 
control (mock-infected cells) was used for the next 
passage up to the 4th passage. Cells were observed dai-
ly for the presence of cytopathic effect (CPE).
RNA extraction
All RNA extractions were carried out with TRIzol 
Reagent™ (Invitrogen, Carlsbad, CA, USA) according 
to manufacturer`s instructions.
Reverse-transcription polymerase chain reaction 
(RT-PCR) to the 5a protein mRNA
For the detection of viral transcription activity, each 
passage (CRG-BETA and control) was monitored for 
the presence of mRNA of the non-structural protein 
5a of IBV.
Complementary DNA was synthesized with M-MLV 
Reverse Transcriptase™ (Invitrogen, Carlsbad, CA, 
USA) according to manufacturer’s instructions using 
the anti-sense primer M41N-AS 5’ CACACGTTAA-
GATGTGTTTTGGTCC 3’, complementary to posi-
tions 164 to 188 of the 5a gene sequences AY392047.1, 
X03448.1, DQ834384.1 and AY851295.1.
PCR was carried out with Platinum Taq DNA Poly-
merase™ (Invitrogen, Carlsbad, CA, USA) accord-
ing to manufacturer`s instructions and an annealing 
temperature of 48ºC with the antisense (M41N-AS) 
and sense (Niña-S 5’ TCTATCACACTAGCCTT-
GCGCTAGA 3’, nucleotides 25 to 49 of sequences 
AY392047.1, X03448.1, DQ834384.1 and AY851295.1, 
correspondent to the leader sequence). After agarose 
gel electrophoresis strained with ethidium bromide, 
reactions with the predicted 164bp amplicons were 
considered as positives.
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RT-PCR for the S1 subunit of the spike glycoprotein 
gene
Each passage (CRG-BETA and control) was sub-
mitted to an RT-PCR targeted to the amplification 
of a 390bp fragment of the region coding for the S1 
subunit of the spike glycoprotein  (nt 705 to 1094) as 
described by Worthington, Currie and Jones8 using 
M-MLV Reverse Transcriptase™ (Invitrogen, Carls-
bad, CA, USA) according to manufacturer’s instruc-
tions and Random Primers ™ (Invitrogen, Carlsbad, 
CA, USA) for the cDNA synthesis and Platinum Taq 
DNA Polymerase™ (Invitrogen, Carlsbad, CA, USA) 
according to manufacturer`s instructions for the first 
round and nested PCRs.
DNA sequencing
S1 amplicons were purified from agarose gels using 
Ilustra™ GFX PCR DNA and Gel Band Purification kit 
(GE Healthcare, USA), bi-directional DNA sequenc-
ing was carried out with BigDye 3.1™ (Applied Biosys-
tems Cidade, País) and sequences resolved in an ABI-
3130™ Automatic Sequences (Applied Biosystems™).
Chromatograms were analyzed with Phred online 
(http://asparagin.cenargen.embrapa.br/phph/) and 
only positions with scores higher than 20 were used. 
Sequences were assembled with Cap-Contig and 
aligned with CLUSTAL/W using Bioedit v. 5.0.99.
RT-PCR for NewCastle Disease Virus (NDV)
All passages, including the mock-infected controls, 
were monitored for NDV as described by Tiwari et al.10.
Results
Passages in VERO cells
Syncytia were observed from the first to the third 
passage (Figure 1B), while no alterations were detect-
ed in the mock-infected monolayers (Figure 1A). By 
the 4th passage, no CPE was detected.
RT-PCRs to the 5a protein mRNA and S1 subunit
Passages 1 to 4 and 1 to 3 of CRG-BETA in VERO 
cells resulted positive for the RT-PCR to the S1 region 
and to the 5a mRNA, respectively, while no amplifica-
tions were detected in the mock-infected cells.
DNA sequencing
The partial sequences of the S1 were obtained 
for passages 2 to 4 and from the original CRG-BE-
TA strain in embryos.  No mutations were detected 
amongst the four sequences in the 316nt alignment 
obtained (Figure 2).
RT-PCR for (NDV)
All VERO cells passages of CRG-BETA were found 
positive for NDV. No NDV was detected in the mock-
infected monolayers.
Figure 1 -  VERO cells monolayers 100 hours post-infection with mock inoculum (A) or CRG-BETA IBV (B) at the 3rd 
passage; 100x magnification
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Discussion
In this study, a Brazilian genotype IBV strain was 
serially passaged in VERO cells and no mutations in 
a region of the S1 subunit nucleotide sequences were 
detected.
The detection of mRNA transcription, achieved 
in this study with an RT-PCR to the 5a gene mRNA, 
clearly demonstrates that the CRG-BETA strain is 
replicating in the cells and that the RNA detected is 
not genomic or inoculum-derived.
In association with the appearance of syncytia, a 
typical IBV cytopathic effect in cell culture5, these re-
sults demonstrate that, at least up to the third passage, 
this strain was able to replicate and to spread from cell 
to cell with the methods employed herein.
Nonetheless, is noteworthy that passage 4 produced 
no CPE or mRNA was detected. One can hypoth-
esize that CRG-BETA was present in a high titer in 
the original, embryo-derived, strain and was thus able 
to efficiently replicate in the first passages due to the 
high IBV population number present in the inocu-
lum, but, arguably due to intense selection, the IBV 
population might have decrease to a low number at 
the 4th passage, entering in a bottleneck phase. A high-
er number of passages is necessary to verify this effect 
and the quantization of mRNA transcripts by qPCR 
would also shed some light on that.
The stability of the S1 region analyzed is also an in-
teresting finding, as others5 have described a less mu-
tation-robust spike gene for IBV passages in VERO 
cells using the Beaudette strain as an inoculum.
The Beaudette strain belongs to the Massachusetts 
serotype of IBV, while CRG-BETA is a Brazilian geno-
type one, with a maximum reported nucleotide iden-
tity of 79.3% for this S1 region amongst these types3. 
As the spike protein plays a major role in receptor-
binding11, it can be speculated that this difference in 
S might have played a role in the different evolution-
ary pathways specifically endowing CRG-BETA with 
a more mutation-robust S when replicating in VERO 
cells. Anyhow, again this speculation must be taken 
with care, as further passages and large S sequences 
would be necessary to assess its consistency. Also, as 
non-structural proteins might play an important role 
in pathogenesis2, differences in these proteins might 
Figure 2 - Partial S1 subunit sequences of IBV strain CRG-BETA ate the second, third and fourth passages in VERO cells 
and the original strain in embryos
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also have accounted for a different host-virus rela-
tionship in the cytoplasmic environment.
Finally, the presence of NDV must also be accom-
modated in the hypothesis for the evolutionary pat-
terns described herein. It’s known that co-infecting 
viruses, such as IBV and Avian metapneumovirus 
might interfere with each other’s replication in vivo 
due to receptor competition12 and thus NDV might 
have outreplicated IBV CRG-BETA in the monolayers 
and led it to extinction.
As a conclusion, an exclusive evolutionary pattern 
of a Brazilian genotype IBV strain has been detected 
which might serve as a model not only for the assess-
ment of vaccine strain stability, but also for a deeper 
understanding of co-evolution co-infecting viruses in 
vivo and in vitro.
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